APhA urges FDA to put patient safety first in review of peptide substances

APhA urges FDA to put patient safety first in review of peptide substances

The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.